“In a typical resource-limited setting like ours, nobody has an electron microscope,” Aniweh says ... at mapping the molecular architecture of mitochondria, microtubules and single-celled ...

The FDA has extended the review period for the New Drug Application for elamipretide for the treatment of Barth syndrome.

Recent studies have shed light on the critical role of cardiolipin in mitochondrial function and how its deficiency can lead to severe health issues in Barth syndrome. For instance, one study ...

Barth syndrome is caused by a mutation in the tafazzin gene, which results in reduced cardiolipin levels, a phospholipid that plays a major role in mitochondrial function. The disease is ...

If approved, this would be the first marketing authorization for elamipretide, a first-in-class mitochondria-targeted therapeutic, and the first FDA-approved therapy for Barth syndrome.

The US Food and Drug Administration (FDA) has delayed its decision on Stealth BioTherapeutics’ new drug application (NDA) for elamipretide, a treatment for the ultra-rare disease Barth syndrome.

Also appointed were former Minister for Power, Prof. Barth Nnaji, as Vice President, and Prof. Jerry Chidozie Chukwuokolo as Secretary until full elections are held to fill other vacant positions.

A senior at Academy of Notre Dame, Katie Barth is a Global Citizen Scholar candidate, a Blue and Gold Key Society member, and active member of Mock Trial and Model UN clubs and started Academy of ...

the researchers used an advanced home-built microscope to look at single proteins on individual DNA molecules. That in itself is an impressive achievement, as Barth explains: "A single cell ...

Formulated using clinically tested natural ingredients, the formula aims to enhance energy, metabolism, and overall vitality by targeting mitochondrial levels in the body. According to the ...